Oncolytics Bio (ONC.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Operating Expenses | 20,693 | 16,663 | 15,605 | 15,295 | 13,918 |
| Operating Income | -20,693 | -16,663 | -15,605 | -15,295 | -13,918 |
| Other Income | -12,430 | 173 | 130 | 164 | 198 |
| Pre-tax Income | -33,123 | -16,489 | -15,475 | -15,131 | -13,720 |
| Income Tax | 0 | 548 | 141 | 9 | 3 |
| Net Income Continuous | -33,123 | -17,037 | -15,617 | -15,140 | -13,723 |
| Net Income | $-33,123 | $-17,037 | $-15,617 | $-15,140 | $-13,723 |
| EPS Basic Total Ops | -1.50 | -1.06 | -1.14 | -1.24 | -1.14 |
| EPS Basic Continuous Ops | -1.50 | -1.06 | -1.14 | -1.24 | -1.14 |
| EPS Diluted Total Ops | -1.50 | -1.06 | -1.14 | -1.24 | -1.14 |
| EPS Diluted Continuous Ops | -1.50 | -1.06 | -1.14 | -1.24 | -1.14 |
| EBITDA(a) | $-20,208 | $-16,567 | $-15,515 | $-15,132 | $-13,737 |